Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
38.68
-0.17 (-0.44%)
Nov 21, 2024, 2:09 PM EST - Market open
Verona Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -153.72 | -54.37 | -68.7 | -55.57 | -65.15 | -40.56 | Upgrade
|
| Depreciation & Amortization | 1.01 | 0.68 | 0.64 | 0.63 | 0.62 | 0.51 | Upgrade
|
| Other Amortization | 0.79 | 0.12 | 0.08 | 0.11 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.29 | - | Upgrade
|
| Stock-Based Compensation | 32.08 | 19.01 | 14.12 | 25.43 | 22.18 | 3.12 | Upgrade
|
| Other Operating Activities | 6.82 | -1.76 | 4.74 | -17.3 | -0.92 | -1.67 | Upgrade
|
| Change in Accounts Receivable | -6.9 | - | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 6.01 | 0.49 | -7.15 | 9.87 | -1.4 | -1.73 | Upgrade
|
| Change in Income Taxes | 6.24 | -2.14 | 4.1 | -6.78 | 0.77 | -3.93 | Upgrade
|
| Change in Other Net Operating Assets | 8.24 | -12.24 | -7.69 | 10.36 | -1.48 | 1.39 | Upgrade
|
| Operating Cash Flow | -103.77 | -50.22 | -59.86 | -33.25 | -45.08 | -42.87 | Upgrade
|
| Capital Expenditures | -0.05 | - | -0.03 | -0.01 | -0.08 | -0.05 | Upgrade
|
| Investment in Securities | - | - | - | - | 9.79 | 47.37 | Upgrade
|
| Investing Cash Flow | -0.05 | - | -0.03 | -0.01 | 9.71 | 47.31 | Upgrade
|
| Long-Term Debt Issued | - | 38.71 | 10 | - | 5 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -5.85 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 98.96 | 38.71 | 4.15 | - | 5 | - | Upgrade
|
| Issuance of Common Stock | 4.48 | 58.86 | 151.17 | 0.73 | 200.2 | - | Upgrade
|
| Repurchase of Common Stock | -15.88 | -4.69 | -4.72 | -6.85 | - | - | Upgrade
|
| Other Financing Activities | 93.07 | -0.01 | -9.78 | - | -12.86 | - | Upgrade
|
| Financing Cash Flow | 180.63 | 92.87 | 140.82 | -6.12 | 192.34 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.85 | 1.3 | -1.48 | -0.22 | 0.58 | 0.74 | Upgrade
|
| Net Cash Flow | 78.67 | 43.95 | 79.45 | -39.61 | 157.56 | 5.19 | Upgrade
|
| Free Cash Flow | -103.81 | -50.22 | -59.89 | -33.27 | -45.16 | -42.92 | Upgrade
|
| Free Cash Flow Margin | -1845.91% | - | -13076.64% | -83.16% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.28 | -0.63 | -0.91 | -0.56 | -1.37 | -3.26 | Upgrade
|
| Cash Interest Paid | 7.23 | 2.01 | 0.35 | 0.22 | 0.01 | - | Upgrade
|
| Cash Income Tax Paid | 0.28 | 1.25 | 0.12 | 0 | 0.01 | - | Upgrade
|
| Levered Free Cash Flow | -60.08 | -36.63 | -33.5 | 2.1 | -18.4 | -28.96 | Upgrade
|
| Unlevered Free Cash Flow | -52.22 | -35.46 | -33.25 | 2.19 | -18.39 | -28.96 | Upgrade
|
| Change in Net Working Capital | -9.31 | 13.61 | 7.91 | -12.2 | -0.15 | 5.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.